Publications of Y. Genzel

Rapp, E., Vester, D., Genzel, Y., Gade, D., & Reichl, U.Quantitative proteomic analysis of influenza A virus infected mammalian cells: Elucidation of virus / host cell interactions with respect to the vaccine production processPresented at: 27th International Symposium & Exhibit on the Separation of Proteins, Peptides & Polynucleotides (ISPPP 2007)Orlando, USA, October 21, 2007.

Ritter, J. B., Genzel, Y., & Reichl, U.Metabolite Analysis in Mammalian Cells: How to generate reliable data sets?Presented at: 20th ESACT meetingDresden, Germany, June 17, 2007.

Genzel, Y., Kalbfuss, B., Ritter, J. B., Schulze-Horsel, J., Rapp, E., Vester, D., & Reichl, U.Characterization and analytical issues on an influenza A virus production processPresented at: Vaccines : Quality control, scale-up and manufactureHamburg, Germany, December 5, 2006.

Genzel, Y. & Reichl, U.Production of vaccines based on animal cell technologyPresented at: Production of Biopharmaceuticals in Animal Cell CulturesRio de Janeiro, Brazil, July 10, 2006.

Genzel, Y. & Reichl, U.Limits and benefits of the interpretation of extracellular metabolite data in mammalian cell culturePresented at: 1st Max Planck Workshop on "Metabolomics"Magdeburg, Germany, April 4, 2006.

Genzel, Y., Sandig, V., & Jordan, I.Neue Zellsubstrate und Einfluss von Medien und Prozessführung in der ImpfstoffproduktionPresented at: 24. DECHEMA-Jahrestagung der BiotechnologenWiesbaden, Germany, September 26, 2006.

Genzel, Y., Schulze-Horsel, J., & Reichl, U.High Cell Density Microcarrier Process in a Wave Bioreactor for the Production of Influenza A VirusPresented at: Vaccine TechnologyPuerto Vallarta, Mexiko, June 25, 2006.

Kalbfuss, B., Wolff, M. W., Genzel, Y., Zimmermann, A., Best, C., Morenweiser, R., & Reichl, U.A generic purification scheme for the production of human influenza vaccines derived from serum-free mammalian cell culturePresented at: Vaccine TechnologyPuerto Vallarta, Mexico, June 25, 2006.

Kalbfuss, B., Wolff, M. W., Genzel, Y., Zimmermann, A., Morenweiser, R., & Reichl, U.Chromatography-based purification of influenza A virus for the production of human whole-virion vaccinesPresented at: ISPPP 2006 : 26th International Symposium on the Separation of Proteins, Peptides and PolynucleotidesInnsbruck, Austria, October 17, 2006.

Ritter, J. B., Genzel, Y., & Reichl, U.Monitoring Energy Metabolism: The Challenge of Intracellular Metabolite Analysis of Mammalian Cells in CulturePresented at: 1st Max Planck Workshop on "Metabolomics"Magdeburg, Germany, April 4, 2006.

Schulze-Horsel, J., Bock, A., Genzel, Y., & Reichl, U.Mammalian cell culture for influenza vaccine production: physiology during cell growth and virus propagation phasePresented at: GVC/DECHEMA-Jahrestagungen 2006 mit 24. DECHEMA-Jahrestagung der BiotechnologenWiesbaden, Germany, September 24, 2006.

Genzel, Y., Schulze-Horsel, J., Möhler, L., Sidorenko, Y., & Reichl, U.Influenza Vaccines: Challenges in Mammalian Cell Culture TechnologyPresented at: 19th ESACT MeetingHarrogate, UK, June 5, 2005.

Genzel, Y., König, S., & Reichl, U.Amino acid analysis in mammalian cell culture based virus vaccine production processesPresented at: IICS : 17th annual International Ion Chromatography SymposiumTrier, Germany, September 20, 2004.

Dogra, T., Pelz, L., Rüdiger, D., Hein, M. D., Böhme, J., Bälkner, M., Kershaw, O., Marichal-Gallardo, P., Gruber, A., Genzel, Y., Bruder, D., Kupke, S. Y., & Reichl, U.Genetically engineered defective interfering particles for antiviral treatment and vaccinationPresented at: 28th ESACT MeetingEdingburgh (Scotland), June 23, 2024.

Jacobtorweihe, L., Göbel, S., Wolschek, M., Altomonte, J., Reichl, U., & Genzel, Y.HCD Perfusion of CCX.E10 Quail Cells for Production of Vesicular Stomatitis Virus based oncolytic VaccinePresented at: Vaccine Technology IXLos Cabos (Mexico), May 19, 2024.

Jacobtorweihe, L., Göbel, S., Wolschek, M., Altomonte, J., Reichl, U., & Genzel, Y.Production of Oncolytic rVSV-NDV in CCX.E10 Quail Cells by HCD Perfusion CulturePresented at: Himmelfahrtstagung on Bioprocess Engineering 2024Regensburg (Germany), May 6, 2024.

Jacobtorweihe, L., Madeline, B., Léon, A., Genzel, Y., & Reichl, U.Production of Oncolytic Newcastle Disease Virus in EB66 cellsPresented at: 28th ESACT MeetingEdingburgh (Scotland), June 23, 2024.

Küchler, J., Opitz, P., Jordan, I., Genzel, Y., Benndorf, D., & Reichl, U.Quantification of intracellular influenza A virus proteins shows changes in dynamics related to host cell line and virus seedPresented at: 28th ESACT Meeting Edingburgh (Scotland), June 23, 2024.

Küchler, J., Opitz, P., Jordan, I., Genzel, Y., Benndorf, D., & Reichl, U.Quantification of intracellular influenza A virus proteins shows changes in dynamics related to host cell line and virus seedPresented at: Himmelfahrtstagung on Bioprocess Engineering 2024Regensburg (Germany), May 6, 2024.

Zinnecker, T. M., Thiele, K., Schmidberger, T., Reichl, U., & Genzel, Y.Influenza A Virus Production following Quality by Design PrinciplesPresented at: Vaccine Technology IXLos Cabos (Mexico), May 19, 2024.